RFID

(redirected from VeriChip)
Also found in: Encyclopedia, Wikipedia.
Related to VeriChip: Rfid

RFID

abbr.
radio frequency identification

RFID

abbreviation for
(Commerce) radio-frequency identity (or identification): a technology that uses tiny computer chips to track items such as consumer commodities at a distance
Translations
RFID
References in periodicals archive ?
VeriChip Corporation (Nasdaq:CHIP), a provider of radio frequency identification (RFID) systems for healthcare and patient-related needs, announced on Tuesday that it has completed its acquisition of Steel Vault Corporation (OTCBB:SVUL), a provider of identity security products and services,
In March 2005 Hackensack University Medical Center in New Jersey began a clinical evaluation program of the ADS VeriChip System in its emergency department.
The VeriChip, made by Applied Digital Solutions (ADS) of Palm Beach, Florida, was approved late last year by the U.
The Food and Drug Administration last fall approved two RFID devices for use in healthcare: The SurgiChip and the VeriChip, both by Fla.
Company literature describes the VeriChip as "a miniaturized, implantable radio frequency identification device (RFID) that has the potential to be used in a variety of security, financial, and other applications.
VeriChip Corporation ("VeriChip" or the "Company") (NASDAQ:CHIP) announced today that it has been selected as a finalist for the South Florida Business Journal's 2009 Technology Awards in the Hardware category.
The VeriChip is a programmable computer chip about the size of a grain of rice that emits a radio signal when a special scanning device is passed over it.
VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) and its development partner RECEPTORS LLC ("RECEPTORS"), a technology company whose AFFINITY by DESIGN[TM] chemistry platform can be applied to the development of selective binding products, announced webcast details for today's event for the medical, patient and investor communities in New York to unveil details of their virus triage detection system for the H1N1 virus and Phase II development of an in vivo glucose-sensing RFID microchip.
amp; MIAMI -- VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) announced today that it has entered into a strategic partnership with the Diabetes Research Institute ("DRI") to combine efforts on the further development of the glucose-sensing radio frequency identification (RFID) microchip in conjunction with VeriChip's development partner, RECEPTORS LLC.
VeriChip Corporation ("VeriChip") (NASDAQ:CHIP) and its development partner RECEPTORS LLC ("RECEPTORS"), a technology company whose AFFINITY by DESIGN[TM] chemistry platform can be applied to the development of selective binding products, announced today they will host an event for the medical, patient and investor communities on October 22, 2009, in New York to unveil details of their virus triage detection system for the H1N1 virus and Phase II development of an in vivo glucose-sensing RFID microchip.
VeriChip Corporation ("VeriChip" or the "Company") (NASDAQ:CHIP) today reviewed its accomplishments for the third quarter ended September 30, 2009.